Several neurotropic cytokines relay their signaling through the leukemia inhibitory factor receptor. This 190 kDa subunit couples with the 130 kDa gp130 subunit to transduce intracellular signaling in neurons and oligodendrocytes that leads to expression of genes associated with neurosurvival. Moreover, activation of this receptor alters the phenotype of immune cells to an anti-inflammatory one. Although cytokines that activate the leukemia inhibitory factor receptor have been studied in the context of neurodegenerative disease, therapeutic targeting of the specific receptor subunit has been understudied in by comparison. This review examines the role of this receptor in the CNS and immune system, and its application in the treatment in stroke and other brain pathologies.
|Number of pages||8|
|Journal||Pharmacology and Therapeutics|
|State||Published - Mar 2018|
Bibliographical noteFunding Information:
Funding was provided by NINDSR01NS091146.
- Brain injury
- Signal transduction
ASJC Scopus subject areas
- Pharmacology (medical)